A unanimous ruling on what a patent holder must allege when a generic label carves out the patented use.
In Recor Medical v. Medtronic Ireland, the Federal Circuit reversed a dismissal of patent infringement counterclaims and held that Medtronic Ireland's retained rights preserved its Article III standing.
US biotech firm Agensys has filed suit in California, accusing Suzhou Zelgen, Shanghai Zelgen, Gensun Biopharma, and Sheng of misappropriating its proprietary LRRC15 antibody technology to support a series of patent applications.
In A.L.M. v. Zydex, the Federal Circuit reversed a dismissal for lack of standing and held that patent owners retaining enforcement and royalty rights have Article III standing.
